Your new experience awaits. Try the new design now and help us make it even better

CASE REPORT article

Front. Genet.

Sec. Cytogenomics

Pediatric-onset Spinocerebellar Ataxia Type 3 with dual ATXN3 and HTT gene mutations: a case report and literature-informed hypothesis

Provisionally accepted
Mengyao  ZhouMengyao Zhou1Dedong  WangDedong Wang1Kang  DuKang Du1Yue  WangYue Wang1Kunzhi  TangKunzhi Tang2Yuanfang  DuanYuanfang Duan1Mengting  ShiMengting Shi2Haohao  WuHaohao Wu1*
  • 1Qujing First People's Hospital, Qujing, China
  • 2Guizhou Provincial People's Hospital, Guiyang, China

The final, formatted version of the article will be published soon.

Spinocerebellar ataxia type 3 (SCA3) is an autosomal dominant neurodegenerative disorder caused by CAG repeat expansion in the ATXN3 gene, typically onsetting in adults aged 30–40 years. Pediatric-onset cases are extremely rare, and concurrent CAG repeat expansions in both ATXN3 and huntingtin (HTT) genes are even more exceptional. Herein, we report a 10-year-old female patient who presented with gait instability and dysarthria as initial symptoms. Diagnosis of SCA3 was confirmed by genetic and radiological evaluations. Genetic testing revealed biallelic CAG repeat lengths of 20 (normal) and 77 (expanded) in ATXN3, and 19 (normal) and 38 (expanded) in HTT. Imaging findings included mild cerebellar atrophy and bilateral tibial exostoses, consistent with her clinical phenotype. Integrated analysis of the case and a review of the literature indicated that the extreme CAG expansion in ATXN3 (77 repeats) is the primary determinant of the remarkably early onset in this patient. The concurrent HTT CAG expansion may also influence the phenotype, suggesting a potential complex interaction that warrants further investigation. This case report provides a clinical example of SCA3 complicated with concurrent ATXN3 and HTT mutations, offering preliminary clinical data for future large-sample studies on the correlation between these two mutations.

Keywords: ATXN3, HTT, pediatric-onset, PolyQ, SCA3

Received: 12 Oct 2025; Accepted: 28 Jan 2026.

Copyright: © 2026 Zhou, Wang, Du, Wang, Tang, Duan, Shi and Wu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Haohao Wu

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.